Aarti Drugs rises as its arm incorporates overseas wholly owned subsidiary

04 Mar 2026 Evaluate

Aarti Drugs is currently trading at Rs. 361.90, up by 4.35 points or 1.22% from its previous closing of Rs. 357.55 on the BSE.

The scrip opened at Rs. 356.95 and has touched a high and low of Rs. 362.95 and Rs. 350.05 respectively. So far 6606 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 574.95 on 21-Jul-2025 and a 52 week low of Rs. 312.50 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 375.00 and Rs. 342.65 respectively. The current market cap of the company is Rs. 3303.06 crore.

The promoters holding in the company stood at 55.03%, while Institutions and Non-Institutions held 12.27% and 32.70% respectively.

Aarti Drugs’ subsidiary -- Pinnacle Chile SpA, has incorporated an overseas wholly owned subsidiary in the name of Tripharma Chile SpA. Accordingly, the newly incorporated company becomes a step-down subsidiary of the Aarti Drugs. The new subsidiary is incorporated for marketing the formulation drugs and participating in tender and private market in Chile. Its business is in line with the business of its holding companies.

Aarti Drugs is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science.

Aarti Drugs Share Price

359.60 2.05 (0.57%)
04-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1749.35
Dr. Reddys Lab 1291.15
Cipla 1312.65
Zydus Lifesciences 896.55
Lupin 2304.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×